12 October 2005
Serco wins UK homeland security contract
Serco Group plc ('Serco') today announces it has signed a contract with the UK
Government to provide solutions to help detect the illicit importation of
radiological substances at UK borders. The contract with the Home Office to
supply equipment, training and support is worth more than £100 million over ten
years. The equipment will be operated by HM Revenue & Customs.
The programme, known as Cyclamen, provides routine screening of traffic at all
types of UK points of entry to prevent the illicit importation of radiological
substances, as part of the Government's counter-terrorism strategy.
Serco Chief Executive Christopher Hyman said:
'We are delighted to cement our partnership with the Home Office and HM Revenue
& Customs with this contract, which allows us to play a vital role in helping
to protect the UK from continuously evolving threats.
'This is a significant success for our new Home Affairs capability. It
underpins our strategy of providing a broad range of specialist services across
the whole Home Affairs arena.'
Ends
Notes to editors
Serco is a leading international service company, operating in a diverse range
of sectors, including home affairs, defence, transport, science, health, IT,
education and local government. More information can be found at
<www.serco.com>
For further information contact:
Richard Hollins, Head of Investor Relations
Dominic Cheetham, Director of Corporate Communications
T +44 (0) 1256 745 900
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.